Kanter, M. C.; Tegeler, C. H.; Pearce, L. A.; Weinberger, J.; Feinberg, W. M.; Anderson, D. C.; Gomez, C. R.; Rothrock, J. F.; Helgason, C. M.; Hart, R. G. (1994). „Carotid stenosis in patients with atrial fibrillation. Prevalence, risk factors, and relationship to stroke in the Stroke Prevention in Atrial Fibrillation Study”. Archives of Internal Medicine. 154 (12): 1372—7. PMID8002689. doi:10.1001/archinte.1994.00420120100011.
Mügge, A.; Kühn, H.; Nikutta, P.; Grote, J.; Lopez, J. A.; Daniel, W. G. (1994). „Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: identification of a subgroup of patients at increased embolic risk.”. Journal of the American College of Cardiology. 23 (3): 599—607. PMID8113541. doi:10.1016/0735-1097(94)90743-9.
Fatkin, D.; Kelly, R. P.; Feneley, M. P. (1994). „Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo”. J AmColl Cardiol. 23 (4): 961—9. PMID8106703. doi:10.1016/0735-1097(94)90644-0.
Pop, G. A.; Meeder, H. J.; Roelandt, J. R.; Van Oudenaarden, W.; Bulens, C.; Verweij, W.; Gijsbers, C.; Van Domburg, R.; Koudstaal, P. J. (1994). „Transthoracic echo/Doppler in the identification of patients with chronic non-valvular atrial fibrillation at risk for thromboembolic events”. European Heart Journal. 15 (11): 1545—51. PMID7835370. doi:10.1093/oxfordjournals.eurheartj.a060428..
Asakura, H.; Hifumi, S.; Jokaji, H.; Saito, M.; Kumabashiri, I.; Uotani, C.; Morishita, E.; Yamazaki, M.; Shibata, K.; Mizuhashi, K. (1992). „Prothrombin fragment F1 + 2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation”. Blood Coagul Fibrinolysis. 3 (4): 469—73. PMID1420823. doi:10.1097/00001721-199203040-00015.
Asinger, R. W.; Koehler, J.; Pearce, L. A.; Zabalgoitia, M.; Blackshear, J. L.; Fenster, P. E.; Strauss, R.; Hess, D.; Pennock, G. D.; Rothbart, R. M.; Halperin, J. L. (1999). „Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: II. Dense spontaneous echocardiographic contrast (The Stroke Prevention in Atrial Fibrillation SPAF-III study)”. J Am Soc Echocardiogr. 12 (12): 1088—96. PMID10588785. doi:10.1016/S0894-7317(99)70106-9.
Collins, L. J.; Silverman, D. I.; Douglas, P. S.; Manning, W. J. (1995). „Cardioversion of nonrheumatic atrial fibrillation. Reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are related to atrial thrombus resolution”. Circulation. 92 (2): 160—3. PMID7600646. doi:10.1161/01.CIR.92.2.160..
Blackshear, J. L.; Pearce, L. A.; Asinger, R. W.; Dittrich, H. C.; Goldman, M. E.; Zabalgoitia, M.; Rothbart, R. M.; Halperin, J. L. (1993). „Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation”. American Journal of Cardiology. 72 (11): 840—3. PMID8213525. doi:10.1016/0002-9149(93)91079-W.
Hart, R. G.; Pearce, L. A.; Miller, V. T.; Anderson, D. C.; Rothrock, J. F.; Albers, G. W.; Nasco, E. (2000). „Cardioembolic vs. Noncardioembolic strokes in atrial fibrillation: Frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies”. Cerebrovascular Diseases. 10 (1): 39—43. PMID10629345. S2CID25791875. doi:10.1159/000016023..
Schmieder, R. E.; Martus, P.; Klingbeil, A. (1996). „Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies”. JAMA. 275 (19): 1507—13. PMID8622227. doi:10.1001/jama.1996.03530430051039..
Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation, I: clinical features of patients at risk. „Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators”. Annals of Internal Medicine. 116 (1): 1—5. 1992. PMID1727091. S2CID26916836. doi:10.7326/0003-4819-116-1-1..
Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation, II: echo- cardiographic features of patients at risk. „Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators”. Annals of Internal Medicine. 116 (1): 6—12. 1992. PMID1727097. S2CID20894266. doi:10.7326/0003-4819-116-1-6..
Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials. „Echocardiographic predictors of stroke in patients with atrial fibrillation: A prospective study of 1066 patients from 3 clinical trials”. Archives of Internal Medicine. 158 (12): 1316—20. 1998. PMID9645825. doi:10.1001/archinte.158.12.1316..
Yoshida, M.; Nakamura, Y.; Higashikawa, M.; Kinoshita, M. (1996). „Predictors of ischemic stroke in non-rheumatic atrial fibrillation”. Int J Cardiol. 56 (1): 61—70. PMID8891806. doi:10.1016/0167-5273(96)02726-X..
Stöllberger, C.; Chnupa, P.; Kronik, G.; Brainin, M.; Finsterer, J.; Schneider, B.; Slany, J. (1998). „Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. ELAT Study Group. Embolism in Left Atrial Thrombi”. Annals of Internal Medicine. 128 (8): 630—8. PMID9537936. S2CID26092143. doi:10.7326/0003-4819-128-8-199804150-00004..
Tsai, L. M.; Lin, L. J.; Teng, J. K.; Chen, J. H. (1997). „Prevalence and clinical significance of left atrial thrombus in nonrheumatic atrial fibrillation”. Int J Cardiol. 58 (2): 163—9. PMID9049681. doi:10.1016/S0167-5273(96)02862-8..
Kanter, M. C.; Tegeler, C. H.; Pearce, L. A.; Weinberger, J.; Feinberg, W. M.; Anderson, D. C.; Gomez, C. R.; Rothrock, J. F.; Helgason, C. M.; Hart, R. G. (1994). „Carotid stenosis in patients with atrial fibrillation. Prevalence, risk factors, and relationship to stroke in the Stroke Prevention in Atrial Fibrillation Study”. Archives of Internal Medicine. 154 (12): 1372—7. PMID8002689. doi:10.1001/archinte.1994.00420120100011.
Mügge, A.; Kühn, H.; Nikutta, P.; Grote, J.; Lopez, J. A.; Daniel, W. G. (1994). „Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: identification of a subgroup of patients at increased embolic risk.”. Journal of the American College of Cardiology. 23 (3): 599—607. PMID8113541. doi:10.1016/0735-1097(94)90743-9.
Fatkin, D.; Kelly, R. P.; Feneley, M. P. (1994). „Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo”. J AmColl Cardiol. 23 (4): 961—9. PMID8106703. doi:10.1016/0735-1097(94)90644-0.
Pop, G. A.; Meeder, H. J.; Roelandt, J. R.; Van Oudenaarden, W.; Bulens, C.; Verweij, W.; Gijsbers, C.; Van Domburg, R.; Koudstaal, P. J. (1994). „Transthoracic echo/Doppler in the identification of patients with chronic non-valvular atrial fibrillation at risk for thromboembolic events”. European Heart Journal. 15 (11): 1545—51. PMID7835370. doi:10.1093/oxfordjournals.eurheartj.a060428..
Asakura, H.; Hifumi, S.; Jokaji, H.; Saito, M.; Kumabashiri, I.; Uotani, C.; Morishita, E.; Yamazaki, M.; Shibata, K.; Mizuhashi, K. (1992). „Prothrombin fragment F1 + 2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation”. Blood Coagul Fibrinolysis. 3 (4): 469—73. PMID1420823. doi:10.1097/00001721-199203040-00015.
Asinger, R. W.; Koehler, J.; Pearce, L. A.; Zabalgoitia, M.; Blackshear, J. L.; Fenster, P. E.; Strauss, R.; Hess, D.; Pennock, G. D.; Rothbart, R. M.; Halperin, J. L. (1999). „Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: II. Dense spontaneous echocardiographic contrast (The Stroke Prevention in Atrial Fibrillation SPAF-III study)”. J Am Soc Echocardiogr. 12 (12): 1088—96. PMID10588785. doi:10.1016/S0894-7317(99)70106-9.
Collins, L. J.; Silverman, D. I.; Douglas, P. S.; Manning, W. J. (1995). „Cardioversion of nonrheumatic atrial fibrillation. Reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are related to atrial thrombus resolution”. Circulation. 92 (2): 160—3. PMID7600646. doi:10.1161/01.CIR.92.2.160..
Blackshear, J. L.; Pearce, L. A.; Asinger, R. W.; Dittrich, H. C.; Goldman, M. E.; Zabalgoitia, M.; Rothbart, R. M.; Halperin, J. L. (1993). „Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation”. American Journal of Cardiology. 72 (11): 840—3. PMID8213525. doi:10.1016/0002-9149(93)91079-W.
Hart, R. G.; Pearce, L. A.; Miller, V. T.; Anderson, D. C.; Rothrock, J. F.; Albers, G. W.; Nasco, E. (2000). „Cardioembolic vs. Noncardioembolic strokes in atrial fibrillation: Frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies”. Cerebrovascular Diseases. 10 (1): 39—43. PMID10629345. S2CID25791875. doi:10.1159/000016023..
Schmieder, R. E.; Martus, P.; Klingbeil, A. (1996). „Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies”. JAMA. 275 (19): 1507—13. PMID8622227. doi:10.1001/jama.1996.03530430051039..
Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation, I: clinical features of patients at risk. „Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators”. Annals of Internal Medicine. 116 (1): 1—5. 1992. PMID1727091. S2CID26916836. doi:10.7326/0003-4819-116-1-1..
Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation, II: echo- cardiographic features of patients at risk. „Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators”. Annals of Internal Medicine. 116 (1): 6—12. 1992. PMID1727097. S2CID20894266. doi:10.7326/0003-4819-116-1-6..
Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials. „Echocardiographic predictors of stroke in patients with atrial fibrillation: A prospective study of 1066 patients from 3 clinical trials”. Archives of Internal Medicine. 158 (12): 1316—20. 1998. PMID9645825. doi:10.1001/archinte.158.12.1316..
Yoshida, M.; Nakamura, Y.; Higashikawa, M.; Kinoshita, M. (1996). „Predictors of ischemic stroke in non-rheumatic atrial fibrillation”. Int J Cardiol. 56 (1): 61—70. PMID8891806. doi:10.1016/0167-5273(96)02726-X..
Stöllberger, C.; Chnupa, P.; Kronik, G.; Brainin, M.; Finsterer, J.; Schneider, B.; Slany, J. (1998). „Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. ELAT Study Group. Embolism in Left Atrial Thrombi”. Annals of Internal Medicine. 128 (8): 630—8. PMID9537936. S2CID26092143. doi:10.7326/0003-4819-128-8-199804150-00004..
Tsai, L. M.; Lin, L. J.; Teng, J. K.; Chen, J. H. (1997). „Prevalence and clinical significance of left atrial thrombus in nonrheumatic atrial fibrillation”. Int J Cardiol. 58 (2): 163—9. PMID9049681. doi:10.1016/S0167-5273(96)02862-8..
Hart, R. G.; Pearce, L. A.; Miller, V. T.; Anderson, D. C.; Rothrock, J. F.; Albers, G. W.; Nasco, E. (2000). „Cardioembolic vs. Noncardioembolic strokes in atrial fibrillation: Frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies”. Cerebrovascular Diseases. 10 (1): 39—43. PMID10629345. S2CID25791875. doi:10.1159/000016023..
Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation, I: clinical features of patients at risk. „Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators”. Annals of Internal Medicine. 116 (1): 1—5. 1992. PMID1727091. S2CID26916836. doi:10.7326/0003-4819-116-1-1..
Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation, II: echo- cardiographic features of patients at risk. „Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators”. Annals of Internal Medicine. 116 (1): 6—12. 1992. PMID1727097. S2CID20894266. doi:10.7326/0003-4819-116-1-6..
Stöllberger, C.; Chnupa, P.; Kronik, G.; Brainin, M.; Finsterer, J.; Schneider, B.; Slany, J. (1998). „Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. ELAT Study Group. Embolism in Left Atrial Thrombi”. Annals of Internal Medicine. 128 (8): 630—8. PMID9537936. S2CID26092143. doi:10.7326/0003-4819-128-8-199804150-00004..